RxDoctor Payments Data

Rebecca Adams, MD

Family Medicine · van Wert, OHNPI 1912988940

Payments from drug & device makers

$1,071in general payments, 2019–2025

Across 57 payments — averaging $18.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$364
  • AbbVie$293
  • Novo Nordisk$86
  • Pfizer$76
  • Astellas Pharma US Inc$42
  • GSK$39
  • plus $171 from 8 others

What the payments were for

  • Food & beverage$1,05598%
  • Entertainment$162%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,071 in reported general payments places this provider in the 60th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$231,010
Medicare patients
386
Services billed
3,196

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban243$124,203
MounjaroTirzepatide56$72,010
TrulicityDulaglutide35$51,454
JanuviaSitagliptin Phosphate57$51,362
OzempicSemaglutide25$39,836
JardianceEmpagliflozin38$33,155
XareltoRivaroxaban42$28,142
Lantus SolostarInsulin Glargine,hum.Rec.Anlog174$23,831
RybelsusSemaglutide11$20,099
FarxigaDapagliflozin Propanediol45$18,405
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog28$17,858
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog16$16,642
Tresiba Flextouch U-100Insulin Degludec12$14,488
Victoza 2-PakLiraglutide25$14,135
MyrbetriqMirabegron14$12,693

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$76$124,203243 claims
Lilly USA, LLCMounjaro, Trulicity$34$123,46491 claims
Novo NordiskOzempic, Rybelsus$86$59,93536 claims
GSKIncruse Ellipta, Breo Ellipta$39$20,49852 claims
Astellas Pharma US IncMyrbetriq$42$12,69314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in van Wert

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →